TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Short Interest Update

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 46,400 shares, a growth of 156.4% from the February 29th total of 18,100 shares. Approximately 2.0% of the company’s stock are sold short. Based on an average daily trading volume, of 26,500 shares, the short-interest ratio is presently 1.8 days.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. AIGH Capital Management LLC raised its holdings in TFF Pharmaceuticals by 70.7% in the third quarter. AIGH Capital Management LLC now owns 2,655,235 shares of the company’s stock worth $929,000 after buying an additional 1,099,709 shares during the last quarter. DRW Securities LLC bought a new stake in shares of TFF Pharmaceuticals in the fourth quarter worth approximately $1,050,000. Vanguard Group Inc. grew its stake in shares of TFF Pharmaceuticals by 6.5% in the first quarter. Vanguard Group Inc. now owns 864,983 shares of the company’s stock worth $5,458,000 after acquiring an additional 52,813 shares during the period. Worth Venture Partners LLC grew its stake in shares of TFF Pharmaceuticals by 66.2% in the third quarter. Worth Venture Partners LLC now owns 646,832 shares of the company’s stock worth $226,000 after acquiring an additional 257,722 shares during the period. Finally, Millennium Management LLC bought a new stake in shares of TFF Pharmaceuticals in the fourth quarter worth approximately $200,000. 15.25% of the stock is owned by hedge funds and other institutional investors.

TFF Pharmaceuticals Stock Down 7.1 %

TFF Pharmaceuticals stock traded down $0.47 during trading hours on Thursday, hitting $6.12. The stock had a trading volume of 14,303 shares, compared to its average volume of 24,910. TFF Pharmaceuticals has a 12-month low of $4.55 and a 12-month high of $21.25. The stock’s 50-day moving average price is $6.69 and its 200-day moving average price is $7.33.

About TFF Pharmaceuticals

TFF Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions.